Baxter Not Expecting ‘Material Litigation’ After Contaminated Heparin Recall

Pharmaceutical giant Baxter announced today that it does not expect any "material" litigation with regards to the contaminated heparin recalls. Although the FDA has received a ton of complaints about death and serious reactions to the drug, Baxter claims that they only know of four possible injuries to date. They also believe it will be difficult to prove a link between the drug and some of the side effects reported by the general public. I think the report on CNN.com gives a little more insight as to why Baxter is not overly concerned with this issue. CNN reports that: Despite the high-profile nature of the heparin troubles, the drug is … [Read more...]